文献速递血液透析通路

下肢透析通路的一期通畅率与生存率均较差

Patients with lower extremity dialysis access have poor primary patency and survival.
PubMed 文献 · J Vasc Surg · 2019-05-27

基于血管质量倡议(VQI)登记库的463例下肢动静脉透析通路病例,其中动静脉瘘(AVF)56例(12.1%)、动静脉移植物(AVG)407例(87.9%)。总体6个月一期通畅率为52.9%,1年生存率为81.9%,5年生存率为65.5%。多因素分析未发现通路类型(AVF vs AVG)与结局显著相关,而外周动脉疾病和肥胖与一期通畅丢失或死亡独立相关。

要点

  • 下肢AV通路6个月一期通畅率仅52.9%,1年死亡率近20%。
  • AVF与AVG在感染、窃血、腿肿胀及通畅/生存结局上无显著差异。
  • 外周动脉疾病和肥胖是一期通畅丢失或死亡的独立危险因素。

核心结论

  • 下肢AV透析通路患者一期通畅率低,1年死亡率接近20%。
  • 选择下肢透析通路时应权衡其较差的通畅与生存结局及其他透析替代方案。

研究设计与样本

  • 回顾性多中心队列研究,数据来源于血管质量倡议(VQI)登记库。
  • 共纳入463例下肢AV透析通路病例,其中AVF 56例(12.1%),AVG 407例(87.9%)。
  • 采用多因素分析评估结局相关因素。

主要发现

  • 总体队列6个月一期通畅丢失自由率为52.9%,6个月任何再干预自由率为75.3%。
  • 1年生存率为81.9%,5年生存率为65.5%。
  • AVF与AVG在6个月伤口感染(12.5% vs 9.6%,P=.571)、缺血性窃血(5% vs 2.2%,P=.273)、腿肿胀(2.5% vs 3.3%,P=.99)方面无差异。
  • 多因素分析显示通路类型(AVF vs AVG)与一期通畅丢失或死亡(HR 0.74,95%CI 0.36-1.5,P=.4)、再干预或死亡(HR 1.65,95%CI 0.82-3.33,P=.163)、死亡(HR 1.94,95%CI 0.71-5.33,P=.197)均无显著关联。
  • 外周动脉疾病(HR 1.6,95%CI 1.06-2.42,P=.03)和肥胖(HR 1.5,95%CI 1.1-2.05,P=.01)与一期通畅丢失或死亡独立相关;肥胖(HR 1.67,95%CI 1.09-2.56,P=.015)与再干预或死亡相关;充血性心力衰竭(HR 1.82,95%CI 1.13-2.94,P=.015)和白种人(HR 1.71,95%CI 1.08-2.73,P=.023)与死亡相关。

临床怎么用

  • 在下肢建立透析通路前,应告知患者一期通畅率低及1年死亡率接近20%的风险。
  • 对于存在外周动脉疾病或肥胖的患者,需更谨慎评估下肢AV通路的获益与风险。
  • 当上肢通路选项耗尽时,下肢AV通路仍可考虑,但应同时权衡其他透析替代方案。

局限性

  • 原文未报告局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Lower extremity arteriovenous (AV) access is an alternative when upper extremity access options have been exhausted. Our goal was to assess short- and medium-term outcomes of lower extremity hemodialysis access. METHODS: The Vascular Quality Initiative was reviewed for all lower extremity AV hemodialysis cases. Patient and case details were recorded. Multivariable analysis was used to analyze outcomes. RESULTS: We identified 463 lower extremity AV access cases in the VQI registry. There were 56 AVF (12.1%) and 407 AVG (87.9%). The mean age was 56 ± 15 years, 46.9% were male, and 40.7% were Caucasian. The majority (90%) had a previous upper extremity AV access and 25.4% had a prior lower extremity access. More than one-half (57.9%) had a tunneled line at the time of the procedure. Patients undergoing an AVF vs AVG creation were younger, more often ambulatory, and less often with peripheral arterial disease. For AVF, the superficial femoral artery was more often used for access inflow (76.8% vs 49.4%; P < .001), compared with AVG, and there was no difference in using femoral vein as the main outflow (78.6% vs 82.6%; P = .466). For AVF, compared with AVG, there was no difference in wound infection (12.5% vs 9.6%; P = .571), ischemic steal (5% vs 2.2%; P = .273), or leg swelling (2.5% vs 3.3%; P = .99) at 6 months. Kaplan-Meier analysis of the overall cohort showed that freedom from loss of primary patency at 6 months was 52.9%, freedom from any reintervention at 6 months was 75.3%, and the 1-year survival was 81.9%. Survival at 5 years was 65.5%. Multivariable analysis showed no significant association of access type (AVF vs AVG) with primary patency loss or death (hazard ratio [HR], 0.74; 95% confidence interval [CI], 0.36-1.5; P = .4), any reintervention or death (HR, 1.65; 95% CI, 0.82-3.33; P = .163), or mortality (HR, 1.94; 95% CI, 0.71-5.33; P = .197). Factors independently associated with primary patency loss or death included peripheral arterial disease (HR, 1.6; 95% CI, 1.06-2.42; P = .03) and obesity (HR, 1.5; 95% CI, 1.1-2.05; P = .01). Any reintervention or death was associated with obesity (HR, 1.67; 95% CI, 1.09-2.56; P = .015). Mortality was associated with congestive heart failure (HR, 1.82; 95% CI, 1.13-2.94; P = .015) and white race (HR, 1.71; 95% CI, 1.08-2.73; P = .023). CONCLUSIONS: In our contemporary multicenter analysis, patients undergoing lower extremity AV access creation have low primary access patency and almost 20% mortality at 1 year. These results should be considered when suggesting a lower extremity dialysis access, as well as other dialysis alternatives when available.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Pike SL, Farber A, Arinze N, et al. Patients with lower extremity dialysis access have poor primary patency and survival. J Vasc Surg. 2019. PMID: 31147128. doi:10.1016/j.jvs.2019.03.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。